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Clinical correlates of splenic histopathology and splenic karyotype in
myeloﬁbrosis with myeloid metaplasia
RubenA. Mesa, Chin-Yang Li, Georgene Schroeder, and Ayalew Tefferi
Splenic extramedullary hematopoiesis is an
integral component of myeloﬁbrosis with
myeloidmetaplasia(MMM)andmaybeclas-
siﬁed into 3 distinct histologic patterns of
inﬁltration by myeloid precursors: diffuse,
nodular, and a predominance of immature
granulocytes. These 3 histologic patterns
occurred in 121 (56.8%), 75 (35.2%), and 17
(8%), respectively, of 213 patients with MMM
who underwent splenectomy at a single
institution. In general, karyotypic ﬁndings in
splenic tissue (n 5 92) were similar to those
seen in the bone marrow. The histologic
pattern of immature granulocyte predomi-
nance, the presence of microscopic splenic
infarcts (26 patients), or the detection of an
abnormal splenic karyotype (52 patients)
wassigniﬁcantlyassociatedwithdecreased
postsplenectomy survival. These adverse
features were also associated with charac-
teristics of advanced disease. These obser-
vations support the bone marrow origin of
the myeloid progenitor pool in the spleen of
patients with MMM and suggest a prognos-
tic value for splenic histopathology and
karyotype. (Blood. 2001;97:3665-3667)
© 2001 by TheAmerican Society of Hematology
Introduction
Speciﬁc extramedullary hematopoiesis (EMH) in myeloﬁbrosis
with myeloid metaplasia (MMM) was originally believed to arise
from reactivation of fetal hematopoietic elements.1 Current evi-
dence suggests that splenic EMH in MMM results from sequestra-
tion,accumulation,andproliferationofcirculatingmyeloidprogeni-
tors in splenic cords.2 Immunohistochemical analysis of splenic
tissue has revealed that EMH in MMM is primarily granulocytic3
as compared with the fetal spleen, which is mainly a site for
erythroid differentiation.4 The bone marrow origin of EMH precur-
sors in MMM has further been suggested by immunohistologic and
morphometric studies of megakaryocytes5 and the in vitro demon-
stration of committed, but not pluripotent, myeloid progenitors in
splenic tissue.6 Splenectomy may be necessary to palliate symp-
toms and improve the quality of life in patients with MMM.7 It was
recently reported that splenic pathology in MMM may undergo a
prognostically relevant progression from an erythroid to a pan-
myeloid composition.8Accordingly, and to provide complementary
information in a recently described series of patients with MMM
who underwent splenectomy,7 we investigated the prognostic value
of splenic histopathology and karyotype.
Study design
Archived splenic tissue obtained from splenectomized patients with MMM
(n 5 213) was stained with hematoxylin and eosin and examined under
light microscopy by one of the authors (C.-Y.L.), who was blinded to the
clinical characteristics and the outcomes of the study patients. All cases
were histologically categorized according to the pattern of myeloid
precursor inﬁltration in the spleen.The 3 categories recognized were diffuse
(diffuse pattern of EMH with trilineage myeloid involvement), nodular
(macronodular proliferation of EMH), and a predominance of immature
granulocytes (immature granulocyte predominance) (Figure 1). In addition,
the presence or absence of microscopic splenic infarctions was noted
(Figure 1), and the results of karyotypic studies in the splenic tissue and
bone marrow were recorded.
Correlations among clinical, histologic, and cytogenetic parameters
were studied by nonparametric statistical techniques. The relations between
categorical variables were studied with the Fisher exact test. When a
continuous variable was divided into 2 categories, the Wilcoxon rank sum
test was used to compare the medians of the continuous variable between
the 2 categories. When a continuous variable was divided into 3 or more
categories, medians of the continuous variable in each of the 3 or more
categories were compared by means of a Kruskal-Wallis test. Kaplan-
Meier9 methodology was used to estimate the distributions of survival from
diagnosis and survival from splenectomy. The log-rank test was used to
assess whether survival from diagnosis and survival from splenectomy
differed between various categories. Multivariate analysis was performed
using logistic regression.
Results and discussion
One hundred twenty-one (56.8%) of the 213 splenectomized
patients with MMM had a diffuse inﬁltrative pattern of EMH that
was composed of granulocytic, erythroid, and megakaryocytic
precursors (diffuse). In another 75 patients (35.2%), this trilineage
inﬁltration of precursors formed a macronodular pattern (nodular).
The histologic pattern in the remaining 17 patients (8.0%) con-
sisted almost exclusively of immature granulocyte precursors
(immature granulocyte predominance). In none of the patients was
the EMH composed strictly of erythroid elements. Results of our
histologic review of MMM splenic tissue are consistent with those
ofpreviousreports.3,10Patientswithimmaturegranulocytepredomi-
nance had unfavorable prognostic scores11 (P 5 .04) and a higher
incidence of cytopenias (erythrocyte transfusion dependence,
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pared with those with more balanced trilineage EMH (nodular or
diffuse) (Table 1). In addition, independent of blastic transforma-
tion, the particular histologic pattern was associated with decreased
overall survival (Figure 2A). The respective median survival times
from diagnosis were 49.4, 64.5, and 90.8 months for immature
granulocyte predominance, diffuse, and nodular EMH histology.
Although direct comparison of the 2 most common histologic
patterns revealed no survival difference, patients with diffuse EMH
had signiﬁcantly worse prognostic scores11 and a higher incidence
of cytopenias (Table 1). Collectively, these observations suggest
that splenic EMH in MMM may initially follow a nodular pattern
and then undergo a prognostically relevant histologic transforma-
tion into a diffuse pattern ﬁrst and granulocyte predomi-
nance second.
Microscopic splenic infarcts were observed in 26 patients and
were not associated with a particular histologic pattern or with the
occurrence of postsplenectomy thrombocytosis or vascular events.
In contrast, their presence was signiﬁcantly associated with an
adverse prognostic score,11 thrombocytopenia, and the presence of
circulating blasts. In addition, patients with splenic infarcts were
Figure 1. Splenic histologic ﬁndings in patients with myeloﬁbrosis with
myeloid metaplasia. (A) Normal spleen (3 128). (B) Diffuse splenic EMH (3 128).
(C) Nodular splenic EMH (3 80). (D) Immature granulocytic predominant EMH
(3 128). (E) Splenic microinfarction (3 51).
Table 1. Results of statistical analysis among splenic histologic subgroups in
213 splenectomized patients with myeloﬁbrosis with myeloid metaplasia
Parameter
Pathology category
(n 5 213)
Diffuse vs
nodular
(n 5 196)
Splenic
infarct
(n 5 26)
General parameters
Number of patients D 5 121 (56.8%) D 5 121 (61.7%) 26 (12.2%)
N 5 75 (35.2%) N 5 75 (38.3%)
PPIG 5 17 (8.0%)
Survival
From diagnosis .04 .17 .01
From splenectomy .29 .82 .02
Cause of death .39 .14 .85
Dupriez score*
At diagnosis .09 .02† , .01
At splenectomy .04 .01 .20
Time to splenectomy
(from diagnosis) .82 .16 .18
Parameters at the time
of splenectomy
Age .99 .53 .38
Laboratory values
Hemoglobin
, 9 g/dL .20 .10 .09
RBC transfusion
dependent
(yes/no) , .01 .02 .09
Leukocyte count .27 .49 .16
Platelet count
, 50 3 109/L , .01 , .01† , .01†
Circulating blasts .44 .44 .04
Spleen mass .70 .10 .63
Splenic infarct
(yes/no) .90 .56 —
Perioperative
complications
Bleeding .87 1.0 .02
Thrombosis 1.0 1.0 .23
Long-term
complications
Leukemia .65 .75 .08
Thrombocytosis .27 1.0 .62
Hepatomegaly .70 .43 .77
All results (except those for distribution) reﬂect a P value from univariate analysis.
Column 1, D vs N vs PPIG; column 2, D vs N only.
Dindicatesdiffuseextramedullaryhematopoiesispattern;N,nodularextramedul-
lary hematopoiesis pattern; PPIG, predominant presence of immature granulocytes
in splenic extramedullary hematopoiesis; RBC, red blood cell.
*Dupriez prognostic score for myeloﬁbrosis with myeloid metaplasia.11
†Signiﬁcant in multivariate analysis using logistic regression.
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(P 5 .08) and to have worse overall and postsplenectomy survival
(Figure 2). Splenic cytogenetic studies were performed in 92
patients, and 52 (56.5%) had an abnormal karyotype (29 single and
23 multiple karyotypic lesions). Speciﬁc abnormalities included
20q2 (n 5 15), 13q2 (n 5 11), 19( n 5 5), abnormalities of
chromosome 5 or 7 (n 5 5), 12p2 (n 5 4), abnormal chromosome
1( n5 4), isochromosome 17q (n 5 3), and 18( n5 2). Of the 92
patients who had splenic karyotype analysis, 68 had information on
bone marrow karyotype that was performed either before (n 5 60)
or after (n 5 8) splenectomy. The karyotypic ﬁndings in the 2
tissues were concordant in more than 85% of cases.Among 9 of the
10 patients who had karyotype discordance between spleen and
bone marrow, the splenic karyotype showed the same clone as in
the bone marrow but with additional chromosomal lesions. Only
one patient had an abnormal karyotype that was found in the bone
marrow but not in the spleen. The presence of an abnormal splenic
karyotype was associated with decreased postsplenectomy survival
(P 5 .03)(Figure2),butnotwithotherclinicopathologicvariables.
The excellent concordance between bone marrow and splenic
cytogenetic clones, as well as our histologic observations, strength-
ens the hypothesis12 that splenic EMH in MMM arises from
ﬁltration of the clonally involved circulating progenitor cells.
Splenic EMH arising in other conditions, such as myelophthisis
from metastatic cancer or marrow stimulation by granulocyte
colony-stimulating factor,13 has also been shown to arise from
ﬁltration of circulating progenitors.14,15 The peripheral blood
progenitor pool in MMM is markedly elevated,16 and its preferen-
tial localization and proliferation in the spleen and liver suggest
that these organs provide an environment conducive to progenitor
growth and differentiation. Our observation concerning the detri-
mental prognostic signiﬁcance of immature granulocyte predomi-
nance of splenic EMH may therefore reﬂect a changing circulating
progenitor pool in advanced MMM.
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Figure 2. Histologic prognostic factors from splenic tissue in 213 patients with myeloﬁbrosis with myeloid metaplasia. (A) Survival from diagnosis according to splenic
EMH. (B) Survival from splenectomy according to the presence of microinfarctions. (C) Survival from splenectomy according to splenic karyotype. PPIG indicates
predominance of immature granulocytes.
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